nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Phlebitis—Aminophylline—chronic obstructive pulmonary disease	0.0141	0.0141	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Roflumilast—chronic obstructive pulmonary disease	0.014	0.014	CcSEcCtD
Ceftaroline fosamil—Infestation—Roflumilast—chronic obstructive pulmonary disease	0.014	0.014	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.0133	0.0133	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Arformoterol—chronic obstructive pulmonary disease	0.0125	0.0125	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Formoterol—chronic obstructive pulmonary disease	0.0125	0.0125	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.0114	0.0114	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.011	0.011	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.011	0.011	CcSEcCtD
Ceftaroline fosamil—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00969	0.00969	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00947	0.00947	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00927	0.00927	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.00893	0.00893	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00878	0.00878	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00869	0.00869	CcSEcCtD
Ceftaroline fosamil—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.00867	0.00867	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.00841	0.00841	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00841	0.00841	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.00794	0.00794	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.00782	0.00782	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.00776	0.00776	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00775	0.00775	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00773	0.00773	CcSEcCtD
Ceftaroline fosamil—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00765	0.00765	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00732	0.00732	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.0072	0.0072	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.0072	0.0072	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00719	0.00719	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00715	0.00715	CcSEcCtD
Ceftaroline fosamil—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00711	0.00711	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00707	0.00707	CcSEcCtD
Ceftaroline fosamil—Infestation—Montelukast—chronic obstructive pulmonary disease	0.00697	0.00697	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.00697	0.00697	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.0069	0.0069	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.0068	0.0068	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.0066	0.0066	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00659	0.00659	CcSEcCtD
Ceftaroline fosamil—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00646	0.00646	CcSEcCtD
Ceftaroline fosamil—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00634	0.00634	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.00631	0.00631	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.00631	0.00631	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.00627	0.00627	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.00627	0.00627	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00626	0.00626	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.00618	0.00618	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00614	0.00614	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00612	0.00612	CcSEcCtD
Ceftaroline fosamil—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00609	0.00609	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00597	0.00597	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00596	0.00596	CcSEcCtD
Ceftaroline fosamil—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00592	0.00592	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00592	0.00592	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00585	0.00585	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00583	0.00583	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00577	0.00577	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00577	0.00577	CcSEcCtD
Ceftaroline fosamil—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00569	0.00569	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00566	0.00566	CcSEcCtD
Ceftaroline fosamil—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00564	0.00564	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00564	0.00564	CcSEcCtD
Ceftaroline fosamil—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00561	0.00561	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00556	0.00556	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00556	0.00556	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00552	0.00552	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00548	0.00548	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00547	0.00547	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00545	0.00545	CcSEcCtD
Ceftaroline fosamil—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00532	0.00532	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00525	0.00525	CcSEcCtD
Ceftaroline fosamil—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00492	0.00492	CcSEcCtD
Ceftaroline fosamil—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00492	0.00492	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00488	0.00488	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00486	0.00486	CcSEcCtD
Ceftaroline fosamil—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00482	0.00482	CcSEcCtD
Ceftaroline fosamil—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00481	0.00481	CcSEcCtD
Ceftaroline fosamil—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00474	0.00474	CcSEcCtD
Ceftaroline fosamil—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00472	0.00472	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00472	0.00472	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00472	0.00472	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.0047	0.0047	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.0047	0.0047	CcSEcCtD
Ceftaroline fosamil—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00464	0.00464	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00461	0.00461	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.0046	0.0046	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00454	0.00454	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00454	0.00454	CcSEcCtD
Ceftaroline fosamil—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00447	0.00447	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00445	0.00445	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00445	0.00445	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00445	0.00445	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00445	0.00445	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00441	0.00441	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00441	0.00441	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.0044	0.0044	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00436	0.00436	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00436	0.00436	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00432	0.00432	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00429	0.00429	CcSEcCtD
Ceftaroline fosamil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00422	0.00422	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00421	0.00421	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00417	0.00417	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00415	0.00415	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00408	0.00408	CcSEcCtD
Ceftaroline fosamil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00398	0.00398	CcSEcCtD
Ceftaroline fosamil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00395	0.00395	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00392	0.00392	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00392	0.00392	CcSEcCtD
Ceftaroline fosamil—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00388	0.00388	CcSEcCtD
Ceftaroline fosamil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00388	0.00388	CcSEcCtD
Ceftaroline fosamil—Pain—Formoterol—chronic obstructive pulmonary disease	0.00388	0.00388	CcSEcCtD
Ceftaroline fosamil—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00388	0.00388	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00384	0.00384	CcSEcCtD
Ceftaroline fosamil—Pain—Montelukast—chronic obstructive pulmonary disease	0.0038	0.0038	CcSEcCtD
Ceftaroline fosamil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00379	0.00379	CcSEcCtD
Ceftaroline fosamil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00376	0.00376	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00376	0.00376	CcSEcCtD
Ceftaroline fosamil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00374	0.00374	CcSEcCtD
Ceftaroline fosamil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00372	0.00372	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00371	0.00371	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00371	0.00371	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.0037	0.0037	CcSEcCtD
Ceftaroline fosamil—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00367	0.00367	CcSEcCtD
Ceftaroline fosamil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00367	0.00367	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00364	0.00364	CcSEcCtD
Ceftaroline fosamil—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00361	0.00361	CcSEcCtD
Ceftaroline fosamil—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00361	0.00361	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Ceftaroline fosamil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00358	0.00358	CcSEcCtD
Ceftaroline fosamil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00355	0.00355	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00354	0.00354	CcSEcCtD
Ceftaroline fosamil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00354	0.00354	CcSEcCtD
Ceftaroline fosamil—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00353	0.00353	CcSEcCtD
Ceftaroline fosamil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00353	0.00353	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00352	0.00352	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00352	0.00352	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00352	0.00352	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00351	0.00351	CcSEcCtD
Ceftaroline fosamil—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00341	0.00341	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00339	0.00339	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00339	0.00339	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00335	0.00335	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00335	0.00335	CcSEcCtD
Ceftaroline fosamil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00334	0.00334	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00331	0.00331	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00328	0.00328	CcSEcCtD
Ceftaroline fosamil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00321	0.00321	CcSEcCtD
Ceftaroline fosamil—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00321	0.00321	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00316	0.00316	CcSEcCtD
Ceftaroline fosamil—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00315	0.00315	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00311	0.00311	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00311	0.00311	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00304	0.00304	CcSEcCtD
Ceftaroline fosamil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00303	0.00303	CcSEcCtD
Ceftaroline fosamil—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00301	0.00301	CcSEcCtD
Ceftaroline fosamil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.003	0.003	CcSEcCtD
Ceftaroline fosamil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.003	0.003	CcSEcCtD
Ceftaroline fosamil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00293	0.00293	CcSEcCtD
Ceftaroline fosamil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00289	0.00289	CcSEcCtD
Ceftaroline fosamil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00289	0.00289	CcSEcCtD
Ceftaroline fosamil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00286	0.00286	CcSEcCtD
Ceftaroline fosamil—Rash—Formoterol—chronic obstructive pulmonary disease	0.00286	0.00286	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00286	0.00286	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00286	0.00286	CcSEcCtD
Ceftaroline fosamil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00285	0.00285	CcSEcCtD
Ceftaroline fosamil—Headache—Formoterol—chronic obstructive pulmonary disease	0.00285	0.00285	CcSEcCtD
Ceftaroline fosamil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00284	0.00284	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00284	0.00284	CcSEcCtD
Ceftaroline fosamil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00283	0.00283	CcSEcCtD
Ceftaroline fosamil—Rash—Montelukast—chronic obstructive pulmonary disease	0.0028	0.0028	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0028	0.0028	CcSEcCtD
Ceftaroline fosamil—Headache—Montelukast—chronic obstructive pulmonary disease	0.00279	0.00279	CcSEcCtD
Ceftaroline fosamil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00273	0.00273	CcSEcCtD
Ceftaroline fosamil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.0027	0.0027	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.0027	0.0027	CcSEcCtD
Ceftaroline fosamil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.0027	0.0027	CcSEcCtD
Ceftaroline fosamil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.0027	0.0027	CcSEcCtD
Ceftaroline fosamil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00269	0.00269	CcSEcCtD
Ceftaroline fosamil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00264	0.00264	CcSEcCtD
Ceftaroline fosamil—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00261	0.00261	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Ceftaroline fosamil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00255	0.00255	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00246	0.00246	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00228	0.00228	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00227	0.00227	CcSEcCtD
Ceftaroline fosamil—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Ceftaroline fosamil—Pain—Prednisolone—chronic obstructive pulmonary disease	0.0021	0.0021	CcSEcCtD
Ceftaroline fosamil—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00202	0.00202	CcSEcCtD
Ceftaroline fosamil—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00195	0.00195	CcSEcCtD
Ceftaroline fosamil—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.0019	0.0019	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00185	0.00185	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00181	0.00181	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00179	0.00179	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00175	0.00175	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00174	0.00174	CcSEcCtD
Ceftaroline fosamil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00163	0.00163	CcSEcCtD
Ceftaroline fosamil—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00155	0.00155	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00155	0.00155	CcSEcCtD
Ceftaroline fosamil—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00154	0.00154	CcSEcCtD
Ceftaroline fosamil—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00153	0.00153	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Ceftaroline fosamil—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Ceftaroline fosamil—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00142	0.00142	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00141	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00141	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Ceftaroline fosamil—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00126	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00122	CcSEcCtD
Ceftaroline fosamil—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00118	0.00118	CcSEcCtD
Ceftaroline fosamil—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00114	CcSEcCtD
Ceftaroline fosamil—Rash—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Ceftaroline fosamil—Headache—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00112	CcSEcCtD
Ceftaroline fosamil—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00106	CcSEcCtD
